These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 33232211)

  • 1. Recombinant vaccines for COVID-19.
    Yadav T; Srivastava N; Mishra G; Dhama K; Kumar S; Puri B; Saxena SK
    Hum Vaccin Immunother; 2020 Dec; 16(12):2905-2912. PubMed ID: 33232211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2.
    Liu Q; Ding Z; Lan J; Wong G
    Methods Mol Biol; 2022; 2410():193-208. PubMed ID: 34914048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.
    Zinatizadeh MR; Zarandi PK; Zinatizadeh M; Yousefi MH; Amani J; Rezaei N
    Biomed Pharmacother; 2022 Feb; 146():112527. PubMed ID: 34906769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in research on the S protein as the target of COVID-19 vaccines.
    Abdalla M; El-Arabey AA; Jiang X
    Expert Rev Vaccines; 2021 Jul; 20(7):769-772. PubMed ID: 33853488
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronavirus Disease 2019 Vaccine Development: An Overview.
    Sumirtanurdin R; Barliana MI
    Viral Immunol; 2021 Apr; 34(3):134-144. PubMed ID: 32985963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants.
    Li C; Guo Y; Fang Z; Zhang H; Zhang Y; Chen K
    Front Immunol; 2022; 13():804945. PubMed ID: 35572594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 11. Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar T; Raut D; Bhatt LK
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
    Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
    Front Immunol; 2021; 12():657711. PubMed ID: 33777055
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19).
    Singh AK; Maurya A; Mishra G; Awasthi R; Dua K; Kulkarni GT
    Recent Pat Nanotechnol; 2023; 17(1):15-17. PubMed ID: 34303337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iran hopes to defeat COVID with home-grown crop of vaccines.
    Mallapaty S
    Nature; 2021 Aug; 596(7873):475. PubMed ID: 34404947
    [No Abstract]   [Full Text] [Related]  

  • 15. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
    Xia X
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for childhood vaccination against COVID-19?
    Eberhardt CS; Siegrist CA
    Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination.
    Bisgin A; Sanlioglu AD; Eksi YE; Griffith TS; Sanlioglu S
    Hum Gene Ther; 2021 Jun; 32(11-12):541-562. PubMed ID: 33858231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccines Based on Adenovirus Vectors.
    Hasanpourghadi M; Novikov M; Ertl HCJ
    Trends Biochem Sci; 2021 May; 46(5):429-430. PubMed ID: 33810926
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.